ANIKA THERAPEUTICS INC. - COMMON STOCK

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 Sep 2023 16:01:08 By Nasdaq GlobeNewswire

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

12 Sep 2023 09:00:38 By Nasdaq GlobeNewswire

Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs

17 Aug 2023 18:20:19 By Nasdaq GlobeNewswire

Anika Reports Second Quarter 2023 Financial Results

08 Aug 2023 16:05:39 By Nasdaq GlobeNewswire

Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

20 Jul 2023 16:05:56 By Nasdaq GlobeNewswire

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

12 Jul 2023 09:00:34 By Nasdaq GlobeNewswire

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

30 May 2023 16:05:37 By Nasdaq GlobeNewswire

Anika Reports First Quarter 2023 Financial Results

09 May 2023 16:05:59 By Nasdaq GlobeNewswire

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

19 Apr 2023 08:30:34 By Nasdaq GlobeNewswire

Anika Enters Into Cooperation Agreement with Caligan Partners

13 Apr 2023 17:00:25 By Nasdaq GlobeNewswire

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

12 Apr 2023 09:00:46 By Nasdaq GlobeNewswire

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

03 Apr 2023 09:00:52 By Nasdaq GlobeNewswire

Anika Files Preliminary Proxy Statement

27 Mar 2023 08:55:17 By Nasdaq GlobeNewswire

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

15 Mar 2023 16:01:26 By Nasdaq GlobeNewswire

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

08 Mar 2023 10:00:26 By Nasdaq GlobeNewswire

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

06 Mar 2023 16:05:08 By Nasdaq GlobeNewswire

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

28 Feb 2023 09:00:29 By Nasdaq GlobeNewswire

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

21 Feb 2023 10:30:01 By Nasdaq GlobeNewswire

Anika Issues Statement

21 Feb 2023 10:00:38 By Nasdaq GlobeNewswire

Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

13 Feb 2023 08:30:13 By Nasdaq GlobeNewswire